Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone

We report long-term survival and toxicity data in a cohort of patients treated in a single institution.

Source: Brachytherapy - March 3, 2019 Category: Cancer & Oncology Authors: Aaron R. Kent, Bronwyn Matheson, Jeremy L. Millar Source Type: research